Trump Can’t Beat Facebook, Twitter and YouTube in Court – but the Fight Might Be Worth More Than a Win
Trump is back for another misguided, erm, quixotic fight. Could he still score points?
Read more...Author Archives: Yves Smith
Moving the Covid Vaccine Goalposts
The Covid propagation and vaccine news is not pointing to happy outcomes
Read more...Wall Street Journal Fingers Columbia as Leader in Grad Students Whose Student Debt Leaves Them ‘Financially Hobbled for Life’
Columbia stands out in what a bad deal its graduate arts programs are. And President Bollinger is either clueless or indifferent.
Read more...The Future of Alzheimer’s Pharmaceutical Aducanumab – as a Medicine and as a Financial Product – What Happens Now?
The more you look at aducanumab, both the dubious FDA approval and the thin odds that it will perform medically, the less there is to like.
Read more...War on Science Persists Within Biden EPA as Staffers Allege Chemical Reports Altered
Whistleblowers charge that Trump-style doctoring of scientific reports is continuing under Biden.
Read more...How Intel Financialized and Lost Leadership in Semiconductor Fabrication
Intel is the poster child of how stock buybacks come at the cost of technological innovation.
Read more...The Real Reason OPEC Talks Broke Down
OPEC is squabbling again. Will the factions settle their hash?
Read more...Buyers’ Strike? Mortgage Applications Drop 8% Below 2019, as Home Buyers Get Second Thoughts about “Raging Mania”
Falling mortgage applications and rising home inventories signal a coming housing market pullback.
Read more...Far More Adults Don’t Want Children Than Previously Thought
Probling why more people arent interested in having children.
Read more...A Quick Comment on China Stomping on Chinese Stock Listings in the US
Another big and costly dustup over Chinese listings in the US. But now Chinese officials signal they want broad-scale change.
Read more...Aducanumab Approval, Part 2: Dirty Drug Dealings
Yves here. We’re doing a bit of catchup by featuring some significant stories that were still crowded out a bit due to the competing news plus the Fourth of July tuneout. One is on the super dodgy approval of the big ticket, very dubious effectiveness Alzheimer’s drug Aducanumab. And “big ticket” is no understatement; the […]
Read more...An Independence Day Reflection: How the Rich Plan to Rule a Burning World
How do the rich intend to carry on as general conditions deteriorate?
Read more...Yanis Varoufakis: Techno-Feudalism Is Taking Over
Varoufakis describes techno-feudalism and speculates on where it is going.
Read more...Why Does Israel Confuse Peace with Surrender?
Offensive military strategies and deliberate use of disproportionate violence against civilians are a core part of Israel policies
Read more...The UK Is Running a Dangerous Covid Experiment That Represents a Threat to the Rest of the World
The Covid infection rates in the UK, despite higher vaccination rates than America, are a danger in and of itself and a warning to the US.
Read more...